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TO THE EDITOR
The article ‘‘Killing two birds with one
stone: oral tofacitinib reverses alopecia
universalis in a patient with plaque
psoriasis’’ by Craiglow and King
reported on the successful treatment of
a patient suffering from both psoriasis
and alopecia areata (Craiglow and King,
2014). The authors observed that before
treatment ‘‘the only prominent hair
growth on the scalp was within areas
of psoriasis (Craiglow and King, 2014).’’
This interesting clinical finding of
exclusion or withdrawal of one
inflammatory condition in the presence
of another has been previously noted
and has been described as a reverse
Ko¨bner reaction or Renbo¨k phenome-
non. The term Renbo¨k was first coined
by Happle in 1991 in an article des-
cribing three patients with an exclusion
of alopecia areata (hair growth) in areas
of seborrheic dermatitis or psoriasis
(Happle et al., 1991).
It has been suggested that the Renbo¨k
phenomen occurs as a result of different
T-helper (Th) inflammatory subsets (Th1,
Th2, Th17) amplifying self-sustaining
cytokines while suppressing alternative
pathways (Harris et al., 2010).
Thus, in a plaque of psoriasis, Th17
inflammatory cytokines may polarize
and recruit T cells to a singular
purpose over the exclusion of Th1
inflammatory pathways that occur in
alopecia areata (Harris et al., 2010).
The fact that various targeted bio-
logical treatments such as blockers of
tumor necrosis factor, T-cell surface
receptors, and ILs have been successful
in treating psoriasis but not alopecia
areata seemed to substantiate the
concept that the inflammatory subsets
in these two conditions were distinct.
However, the recent discovery that IL15
has a critical role in the pathogenesis of
alopecia areata (Xing et al., 2014) has
lead to the identification of a shared
pathway that can be targeted by a single
drug. The use of Janus kinase inhibitors
that block IL15 signaling appear to be a
promising therapy for patients with
alopecia areata and/or psoriasis
(Craiglow and King, 2014; Xing et al.,
2014). After treatment with tofacitinib,
the Renbo¨k phenomenon noted in this
case report resolved (Craiglow and King,
2014). The hair regrowth and resolution
of psoriasis suggest that the inflam-
matory pathways that were perpetua-
ting disease, as well as those leading
to exclusion or cross-regulation, were
either suppressed or normalized. A
further understanding of the mech-
anisms leading to the Renbo¨k pheno-
menon will hopefully provide insights
into the nuances and complex orche-
strations of the inflammatory pathways
seen in alopecia areata and psoriasis.
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